UNSPSC 51393607: Protokylol hydrochloride

This classification denotes a beta-adrenergic agonist with the molecular formula C18H21NO5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7U7O8Q48IO, chemically known as 1-(3,4-dihydroxyphenyl)-2-(alpha-methyl-3,4-methylendioxyphenethylamino)ethanol but more generally known as protokylol hydrochloride, which bears US NIH Compound Identifier 4969. European Medicines Agency schedules Protokylol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04113MIG.

UNSPSC 51393607 Protokylol hydrochloride is a Commodity code that shows minimal relevant recent state and local procurement activity. The two recent opportunities tagged to this code—a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI regarding direct-to-manufacturer prescription programs—do not align with the specific pharmaceutical product this code nominates. Naloxone is an opioid antagonist used in overdose response and is chemically and functionally distinct from protokylol hydrochloride, a beta-blocking agent; similarly, the Texas RFI addresses pharmacy benefit program structure and direct contracting rather than procurement of a named pharmaceutical ingredient. The code appears to reflect a state or local classification artifact rather than active procurement demand for the specific product.

No recent state and local opportunities are currently soliciting protokylol hydrochloride directly. Firms pursuing pharmaceutical procurement opportunities in state and local markets should monitor codes aligned with broader pharmaceutical categories or specific therapeutic classes relevant to their product lines rather than relying on this Commodity code as a sourcing signal. The mismatch between the code's nominal scope and the recent opportunities suggests that state and local jurisdictions may use pharmaceutical product codes inconsistently or that demand for protokylol hydrochloride specifically is not currently captured in active state and local solicitations.